Arrhythmias & electrophysiologyCohort study

Clinical Outcomes by Sex After Pulsed Field Ablation of Atrial Fibrillation

JAMA CardiolPublished

  • Retrospective cohort study
  • multinational
  • registry
  • 24 European centres

Authors' conclusion

Results of this cohort study suggest that after PFA for AF, there were no significant sex differences in clinical effectiveness or safety events.

Study context

Population
Consecutive adults undergoing first-ever pulsed field ablation (PFA) for paroxysmal or persistent atrial fibrillation (AF), MANIFEST-PF registry, March 2021–May 2022
Participants
1,568 adults
Exposure
Female vs male patients after PFA for AF
  • Femalen = 553
  • Malen = 1,015reference
Outcome
Freedom from clinically documented atrial arrhythmia ≥30 s after a 3-month blanking period; safety: composite of acute (<7 days) and chronic (>7 days) major adverse events
Follow-up
Median 1 year

Main finding

As reported in the abstract

Freedom from atrial arrhythmia (Kaplan-Meier estimate)

P = 0.28

Observational data: associations, not effects.

Further findings

PVI performed

Additional ablation performed

  • PVI performed: P = .90
  • Additional ablation performed: P = .79

Safety

Acute major AEs

  • Acute major AEs: no significant difference, P = .19

Original publication

Clinical Outcomes by Sex After Pulsed Field Ablation of Atrial Fibrillation. JAMA Cardiol. Published 1 December 2023. doi:10.1001/jamacardio.2023.3752

Summarised from the published abstract; every number is checked against it